Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.
Borcoman E, Santana Dos Santos E, Genestie C, Pautier P, Lacroix L, Caputo SM, Cabaret O, Guillaud-Bataille M, Michels J, Auguste A, Leary A, Rouleau E.
Borcoman E, et al.
Int J Mol Sci. 2023 Jul 18;24(14):11570. doi: 10.3390/ijms241411570.
Int J Mol Sci. 2023.
PMID: 37511329
Free PMC article.